Cancer BiologyCell ReportsPeer-reviewed
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer
Stephen Tang, Nebiyou Y. Metaferia, Marina F. Nogueira…·Srinivas R. Viswanathan
This study identifies PRMT1 as a critical regulator of AR signaling in prostate cancer through genome-scale CRISPR screening and shows its potential as a therapeutic target.
DOI 10.1016/j.celrep.2022.110417